AKT1 amplification regulates cisplatin resistance in human lung cancer cells through the mammalian target of rapamycin/p70S6K1 pathway

被引:174
|
作者
Liu, Ling-Zhi
Zhou, Xiang-Dong
Qian, Guisheng
Shi, Xianglin
Fang, Jing
Jiang, Bing-Hua [1 ]
机构
[1] Nanjing Med Univ, Ctr Canc, Nanjing 210029, Jiangsu, Peoples R China
[2] Xinqiao Hosp, Inst Resp Dis, Chongqing, Peoples R China
[3] Third Mil Med Univ, Dept Resp Dis, Southwest Hosp, Chongqing, Peoples R China
[4] Chinese Acad Sci, Inst Nutr Sci, Shanghai Inst Biol Sci, Shanghai, Peoples R China
[5] W Virginia Univ, Mary Babb Randolph Canc Ctr, Dept Microbiol Immunol & Cell Biol, Morgantown, WV 26506 USA
关键词
D O I
10.1158/0008-5472.CAN-06-4261
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cisplatin [cis-diaminodichloroplatinum (II) (CDDP)] is one of the most widely used and effective therapeutic agents for many kinds of cancers. However, its efficiency is limited due to development of drug resistance. In this study, we showed that CDDP resistance was associated with AKT1 overexpression and gene amplification in human lung cancer cells that acquired the drug resistance. We showed that AKT1 forced expression in the cells was sufficient to render the cells CDDP resistant, and that AKT1 inhibition by its dominant negative mutant reversed the CDDP-resistant cells to be CDDP sensitive. These results show that AKT1 activity is essential for regulating CDDP resistance in cultured lung cancer cells. To study whether these results were correlated with human lung cancer tumors, we randomly selected tumor samples from human lung cancer patients to study the correlation of AKT activation and CDDP resistance in clinical tumor samples. We showed that AKT activation was highly related to CDDP chemosensitivity in human tumor tissues. Our results further showed that AKT1 induced lung cancer cells to become resistant to CDDP through the mammalian target of the rapamycin (mTOR) signaling pathway. These studies conclude that AKT amplification and the mTOR pathway p ay an important role in human lung cancer cells acquiring CDDP resistance, which represents a new mechanism for acquiring CDDP resistance and a potential novel therapeutic target for overcoming CDDP resistance in human cancer in the future.
引用
收藏
页码:6325 / 6332
页数:8
相关论文
共 50 条
  • [21] Constitutive activation of mammalian target of rapamycin (mTOR) and p70S6K in prostate cancer
    Zotalis, G
    Wood, GC
    Brown, RE
    LABORATORY INVESTIGATION, 2006, 86 : 170A - 170A
  • [22] Ginsenoside CK induces apoptosis and suppresses proliferation and invasion of human osteosarcoma cells through the PI3K/mTOR/p70S6K1 pathway
    Chen, Kang
    Jiao, Jianbao
    Xue, Jinwei
    Chen, Taoping
    Hou, Yu
    Jiang, Yuantao
    Qian, Ligang
    Wang, Yunfei
    Ma, Zheng
    Liang, Zhixing
    Sun, Bo
    Ren, Qiao
    ONCOLOGY REPORTS, 2020, 43 (03) : 886 - 896
  • [23] Oral Administration of Apigenin Inhibits Metastasis through AKT/P70S6K1/MMP-9 Pathway in Orthotopic Ovarian Tumor Model
    He, Jun
    Xu, Qing
    Wang, Min
    Li, Chongyong
    Qian, Xu
    Shi, Zhumei
    Liu, Ling-Zhi
    Jiang, Bing-Hua
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2012, 13 (06): : 7271 - 7282
  • [24] Alterations of Akt1 (PKBα) and p70S6K in transient focal ischemia
    Janelidze, S
    Hu, BR
    Siesjö, P
    Siesjö, BK
    NEUROBIOLOGY OF DISEASE, 2001, 8 (01) : 147 - 154
  • [25] PP242 suppresses bladder cancer cell proliferation and migration through deactivating the mammalian target of rapamycin complex 2/AKT1 signaling pathway
    Zhang, Zhe
    Zhang, Guojun
    Kong, Chuize
    Gong, Daxin
    MOLECULAR MEDICINE REPORTS, 2016, 13 (01) : 333 - 338
  • [26] The mTOR/p70S6K1 signaling pathway in renal fibrosis of children with immunoglobulin A nephropathy
    Xu, Yuanyuan
    Ling, Yihong
    Yang, Fan
    Deng, Jiong
    Rong, Liping
    Jiang, Mengjie
    Jiang, Xiaoyun
    JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, 2017, 18 (03)
  • [27] microRNA-199a is able to reverse cisplatin resistance in human ovarian cancer cells through the inhibition of mammalian target of rapamycin
    Wang, Zhongxian
    Ting, Zhou
    Li, Ya
    Chen, Gang
    Lu, Yunping
    Hao, Xing
    ONCOLOGY LETTERS, 2013, 6 (03) : 789 - 794
  • [28] Genistein promotes apoptosis of lung cancer cells through the IMPDH2/AKT1 pathway
    Xu, Hao
    Ma, Hongda
    Zha, Lifen
    Li, Qian
    Pan, Huiming
    Zhang, Ladi
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2022, 14 (10): : 7040 - 7051
  • [29] G1 cell cycle progression and the expression of G1 cyclins are regulated by PI3K/AKT/mTOR/p70S6K1 signaling in human ovarian cancer cells
    Gao, N
    Flynn, DC
    Zhang, Z
    Zhong, XS
    Walker, V
    Liu, KJ
    Shi, XL
    Jiang, BH
    AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2004, 287 (02): : C281 - C291
  • [30] Role of mTOR/p70S6K1 signaling pathway in tubulointerstitial fibrosis of children with IgA nephropathy
    Ling, Yi-hong
    Jiang, Xiao-yun
    Jiang, Meng-jie
    Chen, Li-zhi
    Sun, Liang-zhong
    Mo, Ying
    PEDIATRIC NEPHROLOGY, 2013, 28 (08) : 1352 - 1352